{"id":"https://openalex.org/W4362545857","doi":"https://doi.org/10.1158/2326-6066.c.6548332.v1","title":"Data from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer","display_name":"Data from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362545857","doi":"https://doi.org/10.1158/2326-6066.c.6548332.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.6548332.v1","doi":"https://doi.org/10.1158/2326-6066.c.6548332.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6548332.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/2326-6066.c.6548332.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025173076","display_name":"Jai Rautela","orcid":"https://orcid.org/0000-0002-4253-9966","observed_orcids":["https://orcid.org/0000-0002-4253-9966"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jai Rautela","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079911978","display_name":"Nikola Baschuk","orcid":"https://orcid.org/0009-0009-0443-6016","observed_orcids":["https://orcid.org/0009-0009-0443-6016"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikola Baschuk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087180556","display_name":"Clare Y. Slaney","orcid":"https://orcid.org/0000-0002-6986-6115","observed_orcids":["https://orcid.org/0000-0002-6986-6115"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clare Y. Slaney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113934564","display_name":"Krishnath M. Jayatilleke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Krishnath M. Jayatilleke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101555874","display_name":"Kun Xiao","orcid":"https://orcid.org/0000-0001-6588-0457","observed_orcids":["https://orcid.org/0000-0001-6588-0457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kun Xiao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110080160","display_name":"Bradley N. Bidwell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradley N. Bidwell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024019080","display_name":"Erin C. Lucas","orcid":"https://orcid.org/0000-0003-3577-7605","observed_orcids":["https://orcid.org/0000-0003-3577-7605"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erin C. Lucas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049789656","display_name":"Edwin D. Hawkins","orcid":"https://orcid.org/0000-0002-3686-8261","observed_orcids":["https://orcid.org/0000-0002-3686-8261"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edwin D. Hawkins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012602578","display_name":"Peter W. Lock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Lock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021283020","display_name":"Christina S.F. Wong","orcid":"https://orcid.org/0000-0002-1650-5383","observed_orcids":["https://orcid.org/0000-0002-1650-5383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina S. Wong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039692056","display_name":"Weisan Chen","orcid":"https://orcid.org/0000-0002-5221-9771","observed_orcids":["https://orcid.org/0000-0002-5221-9771"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weisan Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102010745","display_name":"Robin L. Anderson","orcid":"https://orcid.org/0000-0002-6841-7422","observed_orcids":["https://orcid.org/0000-0002-6841-7422"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robin L. Anderson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035018866","display_name":"Paul J. Hertzog","orcid":"https://orcid.org/0000-0002-1373-8472","observed_orcids":["https://orcid.org/0000-0002-1373-8472"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul J. Hertzog","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004641684","display_name":"Daniel Mark Andrews","orcid":"https://orcid.org/0000-0002-5896-7885","observed_orcids":["https://orcid.org/0000-0002-5896-7885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel M. Andrews","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037394787","display_name":"Andreas M\u00f6ller","orcid":"https://orcid.org/0000-0002-8618-6998","observed_orcids":["https://orcid.org/0000-0002-8618-6998"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas M\u00f6ller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5045235444","display_name":"Belinda S. Parker","orcid":"https://orcid.org/0000-0002-8333-1926","observed_orcids":["https://orcid.org/0000-0002-8333-1926"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Belinda S. Parker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.0502999983727932,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-i-interferon-signaling","display_name":"type I interferon signaling","score":0.925000011920929},{"id":"https://openalex.org/keywords/host-immunity","display_name":"host immunity","score":0.4830000102519989},{"id":"https://openalex.org/keywords/breast-cancer-metastasis","display_name":"breast cancer metastasis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9419999718666077},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8320000171661377},{"id":"https://openalex.org/keywords/4t1-tumor","display_name":"4T1 tumor","score":0.7039999961853027},{"id":"https://openalex.org/keywords/metastasis-free-survival","display_name":"metastasis-free survival","score":0.6890000104904175},{"id":"https://openalex.org/keywords/anti-metastatic-therapy","display_name":"anti-metastatic therapy","score":0.7950000166893005}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.69060879945755},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.6735237240791321},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5479018688201904},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5330165028572083},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5178066492080688},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.5137439966201782},{"id":"https://openalex.org/C2776187077","wikidata":"https://www.wikidata.org/wiki/Q1888235","display_name":"Mammary tumor","level":4,"score":0.5071508884429932},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.48939672112464905},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.4829356372356415},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4630351960659027},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.44430646300315857},{"id":"https://openalex.org/C2778278966","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Interferon type I","level":3,"score":0.44261863827705383},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.43746134638786316},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.18400079011917114},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.6548332.v1","doi":"https://doi.org/10.1158/2326-6066.c.6548332.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6548332.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.6548332.v1","doi":"https://doi.org/10.1158/2326-6066.c.6548332.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6548332.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2118724857","https://openalex.org/W101979521","https://openalex.org/W172337775","https://openalex.org/W2332404561","https://openalex.org/W3120368463","https://openalex.org/W2015859271","https://openalex.org/W2127161920","https://openalex.org/W1966535852","https://openalex.org/W1794322012","https://openalex.org/W2098506409"],"abstract_inverted_index":{"Abstract":[0],"Metastatic":[1],"progression":[2],"is":[3,37,45,109,173],"the":[4,74,80,86,105,119,122,144,161,184],"major":[5],"cause":[6],"of":[7,41,47,82,91,95,113,121,168],"breast":[8,16,148],"cancer\u2013related":[9],"mortality.":[10],"By":[11],"examining":[12],"multiple":[13],"syngeneic":[14],"preclinical":[15],"cancer":[17],"models":[18],"in":[19,61,85,131,154],"mice":[20,64,141],"lacking":[21],"a":[22,38,110,166,180],"functional":[23],"type-I":[24,33,101,170,186],"interferon":[25,34],"receptor":[26],"(Ifnar1\u2212/\u2212":[27],"mice),":[28],"we":[29,53],"show":[30,54],"that":[31,44,55,99,130,160],"host-derived":[32],"(IFN)":[35],"signaling":[36,103,172],"critical":[39,117],"determinant":[40,112],"metastatic":[42],"spread":[43],"independent":[46],"primary":[48],"tumor":[49,149],"growth.":[50],"In":[51],"particular,":[52],"bone":[56,83],"metastasis":[57,84],"can":[58,142],"be":[59],"accelerated":[60],"Balb/c":[62],"Ifnar1\u2212/\u2212":[63],"bearing":[65],"either":[66],"4T1":[67,145],"or":[68],"66cl4":[69,147],"orthotopic":[70],"tumors":[71],"and,":[72],"for":[73,182],"first":[75],"time,":[76],"present":[77],"data":[78],"showing":[79],"development":[81],"C57Bl/6":[87],"spontaneous":[88],"MMTV-PyMT\u2013driven":[89],"model":[90],"tumorigenesis.":[92],"Further":[93],"exploration":[94],"these":[96],"results":[97],"revealed":[98],"endogenous":[100,185],"IFN":[102,171,187],"to":[104,118,175],"host":[106,169],"hematopoietic":[107],"system":[108],"key":[111],"metastasis-free":[114],"survival":[115],"and":[116,146,178],"responsiveness":[120],"circulating":[123],"natural":[124],"killer":[125],"(NK)\u2013cell":[126],"population.":[127],"We":[128],"find":[129],"vivo\u2013stimulated":[132],"NK":[133],"cells":[134],"derived":[135],"from":[136,165],"wild-type,":[137],"but":[138],"not":[139],"Ifnar1\u2212/\u2212,":[140],"eliminate":[143],"lines":[150],"with":[151],"varying":[152],"kinetics":[153],"vitro.":[155],"Together,":[156],"this":[157],"study":[158],"indicates":[159],"dysregulated":[162],"immunity":[163],"resulting":[164],"loss":[167],"sufficient":[174],"drive":[176],"metastasis,":[177],"provides":[179],"rationale":[181],"targeting":[183],"pathway":[188],"as":[189],"an":[190],"antimetastatic":[191],"strategy.":[192],"Cancer":[193],"Immunol":[194],"Res;":[195],"3(11);":[196],"1207\u201317.":[197],"\u00a92015":[198],"AACR.":[199]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-06T00:00:00"}